Paper14718293
Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.
Hariprasad SM and 6 others. Arch Ophthalmol, 2004. Cited by 216 papers, by iCite.
Cite this record
ConductScience Library. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Papers, record 14718293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14718293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifungal Agents | Major topic |
| Aqueous Humor | Major topic |
| Pyrimidines | Major topic |
| Triazoles | Major topic |
| Vitreous Body | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Biological Availability | |
| Biological Transport | |
| Chromatography, High Pressure Liquid | |
| Female | |
| Fungi | |
| Humans | |
| Male | |
| Microbial Sensitivity Tests | |
| Middle Aged | |
| Prospective Studies | |
| Vitrectomy | |
| Voriconazole |
Source PubMed
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 216 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42593647 | Visual Acuity Influences Visual Outcome in Endophthalmitis: A 10-Year Retrospective Observational Cohort Analysis. | Ophthalmol Ther | 2026 | https://conductscience.org/library/papers/42593647 | PubMed |
| 42480284 | Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children. | Braz J Infect Dis | 2026 | https://conductscience.org/library/papers/42480284 | PubMed |
| 41472061 | Clinical Manifestations, Antifungal Susceptibilities, and Outcome of Ocular Infections Caused by Purpureocillium lilacinum. | Microorganisms | 2025 | https://conductscience.org/library/papers/41472061 | PubMed |
| 41291588 | A rare case of exogenous fungal endophthalmitis following a traumatic corneal insult. | BMC Ophthalmol | 2025 | https://conductscience.org/library/papers/41291588 | PubMed |
| 41143137 | Efficacy of Rezafungin on Candida albicans Endophthalmitis in a Rabbit Model. | Pathog Immun | 2025 | https://conductscience.org/library/papers/41143137 | PubMed |
| 40895956 | Aspergillus flavus Keratitis After Penetrating Keratoplasty. | Cureus | 2025 | https://conductscience.org/library/papers/40895956 | PubMed |
| 39502714 | Progression of Sclerouveitis to Endogenous Fusarium Endophthalmitis. | Case Rep Ophthalmol Med | 2024 | https://conductscience.org/library/papers/39502714 | PubMed |
| 38993488 | Histoplasmosis in patients living with HIV in Europe: review of literature. | Front Microbiol | 2024 | https://conductscience.org/library/papers/38993488 | PubMed |
| 38787278 | Humans vs. Fungi: An Overview of Fungal Pathogens against Humans. | Pathogens | 2024 | https://conductscience.org/library/papers/38787278 | PubMed |
| 38534634 | Fungal Endophthalmitis: Clinical Characteristics, Pathogens, and Factors Affecting Visual Outcome. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38534634 | PubMed |
| 38399495 | Use of Optical Coherence Tomography and Optical Coherence Tomography Angiography in the Diagnosis and Follow-Up of Endogenous Candida Endophthalmitis: A Case Report. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/38399495 | PubMed |
| 37250626 | Oral voriconazole monotherapy for fungal keratitis: efficacy, safety, and factors associated with outcomes. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37250626 | PubMed |
| 35769550 | Microbiological Profiles of Ocular Fungal Infection at an Ophthalmic Referral Hospital in Southern China: A Ten-Year Retrospective Study. | Infect Drug Resist | 2022 | https://conductscience.org/library/papers/35769550 | PubMed |
| 35440433 | Aspergillus flavus endogenous endophthalmitis in an immunocompetent man: treatment outcomes and swept-source optical coherence tomography findings. | BMJ Case Rep | 2022 | https://conductscience.org/library/papers/35440433 | PubMed |
| 35225510 | Understanding the science of fungal endophthalmitis - AIOS 2021 Sengamedu Srinivas Badrinath Endowment Lecture. | Indian J Ophthalmol | 2022 | https://conductscience.org/library/papers/35225510 | PubMed |
| 34909437 | Candida Endophthalmitis Treated Successfully With Isavuconazole: A Case Report. | Open Forum Infect Dis | 2021 | https://conductscience.org/library/papers/34909437 | PubMed |
| 34373790 | Efficacy of Voriconazole Corneal Intrastromal Injection for the Treatment of Fungal Keratitis. | J Ophthalmol | 2021 | https://conductscience.org/library/papers/34373790 | PubMed |
| 34002355 | Clinical Pharmacokinetics of Triazoles in Pediatric Patients. | Clin Pharmacokinet | 2021 | https://conductscience.org/library/papers/34002355 | PubMed |
| 33469490 | Endogenous fungal endophthalmitis: risk factors, clinical course, and visual outcome in 13 patients. | Int J Ophthalmol | 2021 | https://conductscience.org/library/papers/33469490 | PubMed |
| 33156370 | Antimicrobial guide to posterior segment infections. | Graefes Arch Clin Exp Ophthalmol | 2021 | https://conductscience.org/library/papers/33156370 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14718293
GET https://conductscience.org/api/papers/v1/14718293/cited_by?page=2